Production of Cor-A clinical trial samples

Corallopyronin A (CorA) is an antibiotic derived from soil bacteria by biotechnological means. Its spectrum of activity includes tropical diseases and multi-resistant bacteria. For CorA to be effective as a capsule, it requires embedding in polymers that improve bioavailability. For clinical trials, certified GMP manufacturing is needed, which is made possible by ForTra (Forschungstransfer der Else Kröner-Fresenius-Stiftung).

Full Press release hereForschungstransfer der Else Kröner-Fresenius-Stiftung